Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02219711
Title Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294 United States Details
University of California, San Diego San Diego California 92093 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
Innovative Clinical Research Institute Whittier California 90602 United States Details
Rocky Mountain Cancer Center Denver Colorado 80218 United States Details
Holy Cross Michael & Dianne Bienes Comprehensive Cancer Center Fort Lauderdale Florida 33308 United States Details
Florida Cancer Affiliates Ocala Florida 34471 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
Maryland Oncology Hematology, Rockville Maryland 20850 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Washington University Center for Advanced Medicine Saint Louis Missouri 63110 United States Details
CHI Health St Francis, Saint Francis Cancer Treatment Center Grand Island Nebraska 68803 United States Details
Oncology Hematology West PC, Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico 87102 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Columbia University New York New York 10032 United States Details
Oncology Hematology Care, Inc. Cincinnati Ohio 45242 United States Details
Guthrie Clinical Research Sayre Pennsylvania 18840 United States Details
St. Francis Cancer Center Greenville South Carolina 29607 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Texas Oncology-Austin Midtown Austin Texas 78705 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75251 United States Details
University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
Texas Oncology-Tyler Tyler Texas 75702 United States Details
The Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Oncology and Hematology Associates of Southwest Virginia, Inc., Blue Ridge Cancer Care Roanoke Virginia 24014 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Northwest Cancer Specialists, P.C. Vancouver Washington 98684 United States Details
University of Wisconsin Madison Wisconsin 53792 United States Details
Chungbuk National University Hospital Cheongju-si Korea, Republic of Details
Keimyung University Dongsan Hospital Daegu Korea, Republic of Details
National Cancer Center Goyang-si Korea, Republic of Details
Korea Veterans Health Service Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field